![Andrew Garschagen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Garschagen
Gestionnaire de Portefeuille-Actions chez
Pembroke Management Ltd.
Profil
Mr. Andrew C.
Garschagen is a Partner, Portfolio Manager & Director at Pembroke Management Ltd. He invests in technology and industrial companies in the US and Canada.
He is also a Director and member of the Investment Committee for the H.L.
Snyder Medical Foundation.
Prioir to joining the Pebmroke in 2016, Mr. Garschagen was previously employed as a Business Analyst & Strategy Consultant by Ernst & Young LLP (Missouri), an Analyst by Blackstone Corporate Private Equity, Kailix Investment Advisors LLC, WR Huff Asset Management Co. LLC, and Kingdon Capital Management LLC, and an Associate by William Blair Capital Partners LLC.
He received his Bachelor’s degree in Asian Studies from Northwestern University and an MBA from the MIT Sloan School of Management.
Postes actifs de Andrew Garschagen
| Sociétés | Poste | Début |
|---|---|---|
Pembroke Management Ltd.
 Pembroke Management Ltd. Investment ManagersFinance Pembroke manages US and Canadian equity mandates which aims to realize long-term capital appreciation primarily through investment in a portfolio of common shares and other equity securities of predominantly small to medium-cap issuers that generally exhibit the potential to achieve above-average long-term earnings or revenue growth. For certain mandates, the firm also invests in large-cap issuers. Their equity mandates are based on a bottom-up assessment of company-specific factors. Pembroke seeks to make investments principally in companies that have the prospect to create wealth over a three to five-year period, the firm will trade securities based on factors such as the market environment, valuation, industry fundamentals, and company-specific developments. | Gestionnaire de Portefeuille-Actions | 01/06/2016 |
Anciens postes connus de Andrew Garschagen
| Sociétés | Poste | Fin |
|---|---|---|
WR Huff Asset Management Co. LLC
 WR Huff Asset Management Co. LLC Investment ManagersFinance WR Huff Asset Management provides their clients with discretionary investment advisory services. While their focus is on high yield bonds, the firm may provide clients with advisory services on a variety of investments, including, but not limited to, other corporate debt securities, equity and equity-related securities, bank debt, commercial paper, United States or other government securities, credit default swaps, interests in master limited partnerships, bankers acceptances, certificates of deposit and repurchase agreements. WR Huff provides investment advisory services utilizing a fundamental approach which includes both qualitative and quantitative analyses. | Corporate Officer/Principal | - |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Corporate Officer/Principal | - |
Kailix Investment Advisors LLC
 Kailix Investment Advisors LLC Investment ManagersFinance Kailix Investment Advisors seeks superior absolute returns by investing globally in a portfolio of primarily of long and short equity investments. The firm focuses on investment opportunities related to growth in developing world economies. They target the energy, basic materials and industrials sectors | Analyst-Equity | 31/12/2009 |
Kingdon Capital Management LLC
 Kingdon Capital Management LLC Investment ManagersFinance Kingdon aims to achieve attractive risk-adjusted returns across all market cycles. The firm adheres to research driven process, investing across geographies, industries and asset classes to find the best use of capital. They offer two investment strategies: a global long/short equity strategy (Flagship Strategy) and a global long/short healthcare strategy (Healthcare Strategy). The Flagship Strategy consists of thematic, idiosyncratic and opportunistic investments with diversified return drivers and an emphasis on liquidity. The Healthcare Strategy primarily invests in the global healthcare industry. | Analyst-Equity | - |
William Blair Capital Partners LLC
 William Blair Capital Partners LLC Investment ManagersFinance William Blair Capital Partners (WBCP) focuses on private placements, PIPES and the investment of funds provided by partners of the firm. They invest in the following sectors: business services, financial services, consumer, healthcare services, healthcare products and technology. Within the business and financial services sectors, WBCP focuses on accounts receivable management, asset management services, data analytics, distribution services, education/educational services, interactive media, niche consulting, payment processing, payroll processing, research products/services, specialty insurance products and specialized marketing services. WBCP seeks investments in outstanding growth companies in the consumer sector. The firm looks for companies that need capital to expand through organic growth, regional expansion or through acquisition of other market players. They focus primarily on two niches within the consumer segment: (1) companies involved in the sale of new and novel products and services to the consumer and companies involved in the sale of well-established products in new and novel ways. WBCP seeks to invest in growing, well-managed companies with strong management teams that are, or have the potential to become, leaders in their market niche. Within the healthcare sector, WBCP invests primarily in the medical devices, biopharmaceuticals and healthcare services industries. The firm looks for innovative companies with products that address unmet medical needs. They are particularly interested in therapeutic areas in which relatively little capital has been historically deployed, including gastroenterology, neurology/neurosurgery and cosmetic surgery and aesthetics. They may also consider investment opportunities in the orthopedic, spine and cardiovascular segments. In the biopharmaceutical industry, WBCP invests primarily in companies that have late-stage (phase II clinical trials or later) compounds or that have approved products. The firm also pursues opportunities to start and nurture pharmaceutical companies in the dermatology, neurology, rheumatology and gastroenterology specialties. WBCP also invests in small market companies with annual revenues of $50 million to $300 million that have not generated strong commercial or development interest from large pharmaceutical companies. WBCP considers investments in healthcare companies that provide services to patients in the outpatient or short-stay settings and in companies that provide outsourced business services to larger healthcare providers such as hospitals or surgery centers. The firm is particularly interested in service companies that pursue segments of the healthcare economy in which the patient pays directly for the service or that provide business-to-business services to healthcare providers. They also invest in companies that provide medical services to governmental healthcare programs such as Medicare and Medicaid. WBCP invests technology companies primarily in the following areas: wireless semiconductors, consumer electronic semiconductors/software, wireless Internet and software as service (SaaS). They firm seeks to invest in companies with (1) platform technology including core technology can be applied to multiple markets across multiple product lines (2) scaleable and capital efficient business models (3) market opportunities that have been validated by customers (4) disruptive technology that is non-disruptive to implement (5) a defensible and sustainable technology lead (6) multiple exit opportunities including acquisition and IPO and (7) compelling growth rates appropriate for their business model. WMCP invests in companies that require funds for product development, sales, marketing and operations. They do not invest in technology development. | Corporate Officer/Principal | 31/12/2002 |
Formation de Andrew Garschagen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Kingdon Capital Management LLC
Kingdon Capital Management LLC Investment ManagersFinance Kingdon aims to achieve attractive risk-adjusted returns across all market cycles. The firm adheres to research driven process, investing across geographies, industries and asset classes to find the best use of capital. They offer two investment strategies: a global long/short equity strategy (Flagship Strategy) and a global long/short healthcare strategy (Healthcare Strategy). The Flagship Strategy consists of thematic, idiosyncratic and opportunistic investments with diversified return drivers and an emphasis on liquidity. The Healthcare Strategy primarily invests in the global healthcare industry. | Finance |
Pembroke Management Ltd.
Pembroke Management Ltd. Investment ManagersFinance Pembroke manages US and Canadian equity mandates which aims to realize long-term capital appreciation primarily through investment in a portfolio of common shares and other equity securities of predominantly small to medium-cap issuers that generally exhibit the potential to achieve above-average long-term earnings or revenue growth. For certain mandates, the firm also invests in large-cap issuers. Their equity mandates are based on a bottom-up assessment of company-specific factors. Pembroke seeks to make investments principally in companies that have the prospect to create wealth over a three to five-year period, the firm will trade securities based on factors such as the market environment, valuation, industry fundamentals, and company-specific developments. | Finance |
WR Huff Asset Management Co. LLC
WR Huff Asset Management Co. LLC Investment ManagersFinance WR Huff Asset Management provides their clients with discretionary investment advisory services. While their focus is on high yield bonds, the firm may provide clients with advisory services on a variety of investments, including, but not limited to, other corporate debt securities, equity and equity-related securities, bank debt, commercial paper, United States or other government securities, credit default swaps, interests in master limited partnerships, bankers acceptances, certificates of deposit and repurchase agreements. WR Huff provides investment advisory services utilizing a fundamental approach which includes both qualitative and quantitative analyses. | Finance |
Blackstone Corporate Private Equity
 Blackstone Corporate Private Equity Investment ManagersFinance Blackstone Corporate invests in middle market companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout and growth stage capital requirements. | Finance |
William Blair Capital Partners LLC
William Blair Capital Partners LLC Investment ManagersFinance William Blair Capital Partners (WBCP) focuses on private placements, PIPES and the investment of funds provided by partners of the firm. They invest in the following sectors: business services, financial services, consumer, healthcare services, healthcare products and technology. Within the business and financial services sectors, WBCP focuses on accounts receivable management, asset management services, data analytics, distribution services, education/educational services, interactive media, niche consulting, payment processing, payroll processing, research products/services, specialty insurance products and specialized marketing services. WBCP seeks investments in outstanding growth companies in the consumer sector. The firm looks for companies that need capital to expand through organic growth, regional expansion or through acquisition of other market players. They focus primarily on two niches within the consumer segment: (1) companies involved in the sale of new and novel products and services to the consumer and companies involved in the sale of well-established products in new and novel ways. WBCP seeks to invest in growing, well-managed companies with strong management teams that are, or have the potential to become, leaders in their market niche. Within the healthcare sector, WBCP invests primarily in the medical devices, biopharmaceuticals and healthcare services industries. The firm looks for innovative companies with products that address unmet medical needs. They are particularly interested in therapeutic areas in which relatively little capital has been historically deployed, including gastroenterology, neurology/neurosurgery and cosmetic surgery and aesthetics. They may also consider investment opportunities in the orthopedic, spine and cardiovascular segments. In the biopharmaceutical industry, WBCP invests primarily in companies that have late-stage (phase II clinical trials or later) compounds or that have approved products. The firm also pursues opportunities to start and nurture pharmaceutical companies in the dermatology, neurology, rheumatology and gastroenterology specialties. WBCP also invests in small market companies with annual revenues of $50 million to $300 million that have not generated strong commercial or development interest from large pharmaceutical companies. WBCP considers investments in healthcare companies that provide services to patients in the outpatient or short-stay settings and in companies that provide outsourced business services to larger healthcare providers such as hospitals or surgery centers. The firm is particularly interested in service companies that pursue segments of the healthcare economy in which the patient pays directly for the service or that provide business-to-business services to healthcare providers. They also invest in companies that provide medical services to governmental healthcare programs such as Medicare and Medicaid. WBCP invests technology companies primarily in the following areas: wireless semiconductors, consumer electronic semiconductors/software, wireless Internet and software as service (SaaS). They firm seeks to invest in companies with (1) platform technology including core technology can be applied to multiple markets across multiple product lines (2) scaleable and capital efficient business models (3) market opportunities that have been validated by customers (4) disruptive technology that is non-disruptive to implement (5) a defensible and sustainable technology lead (6) multiple exit opportunities including acquisition and IPO and (7) compelling growth rates appropriate for their business model. WMCP invests in companies that require funds for product development, sales, marketing and operations. They do not invest in technology development. | Finance |
Ernst & Young LLP (Missouri)
Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kailix Investment Advisors LLC
Kailix Investment Advisors LLC Investment ManagersFinance Kailix Investment Advisors seeks superior absolute returns by investing globally in a portfolio of primarily of long and short equity investments. The firm focuses on investment opportunities related to growth in developing world economies. They target the energy, basic materials and industrials sectors | Finance |
Choisissez Zonebourse 
